Postoperative urinary retention (POUR) is a common complication after total knee arthroplasty. Currently, there are no clinical data regarding the effects of magnesium sulfate on POUR. Here, we investigated the effects of intraoperative magnesium sulfate infusion in patients with POUR following total knee arthroplasty. We reviewed the medical records of patients who underwent elective unilateral total knee arthroplasty under spinal anesthesia between June 2016 and May 2018. The patients were grouped based on whether they were treated with magnesium (magnesium group) or not (control group). We investigated the incidence of POUR and the postoperative analgesic requirement. Totally, 483 patients were included in the analysis. After propensity score matching with the control group, the magnesium group showed a lower incidence of POUR (odds ratio, 0.49; 95% CI, 0.29–0.83; p = 0.011) and lesser opioid consumption (p = 0.049) than the control group. Multivariate logistic regression analysis revealed that intraoperative continuous infusion of magnesium (p = 0.008) and age (p = 0.001) were significantly related to the incidence of POUR. This retrospective observational study demonstrated that administration of magnesium sulfate was associated with a lower incidence of POUR following total knee arthroplasty.
Background: Cancer-related pain management remains challenging, particularly for spinal metastases, in which pain arises from multiple pathological mechanisms. Despite the increasing use of epidural steroid injections (ESI) in clinical practice as part of multimodal pain management, the evidence of their effectiveness in these patients remains limited. Design: A retrospective cohort study. Setting: Three university-affiliated tertiary hospitals in South Korea. Subjects: A total of 123 patients with cancer and radiologically confirmed spinal metastases who underwent ESI between January 2020 and December 2022. Patients were categorized as effective (Group E, ≥50% pain reduction at 1 month, n = 73) or non-effective (Group N, n = 50). Methods: Pain intensity, opioid use, patient satisfaction, repeat procedures, and survival were evaluated at baseline and 1 and 3 months after ESI. In addition, factors influencing the effectiveness of ESI were analyzed. Results: A better performance status (ECOG-PS 1) and lower baseline opioid requirements predicted a favorable ESI response. The Group E maintained pain relief at 3 months with a minimal increase in opioid use, reported higher satisfaction (94.5% vs 6.5%), needed fewer repeat injections (64.4% vs 86.6%), and demonstrated better 6-month survival (78.1% vs 34.0%) than Group N. Conclusion: ESI may be beneficial in reducing pain and attenuating opioid escalation in patients with spinal metastases, especially when the performance status is relatively preserved, and before the initiation of high-dose opioid therapy. These results support early integration of ESI into multimodal cancer pain management strategies.
Background /Objectives: Treatment response after percutaneous epidural neuroplasty (PEN) is heterogeneous. We evaluated clinical, imaging, and procedural factors associated with response after retrodiscal percutaneous epidural neuroplasty (RD-PEN). Methods: This retrospective, single-center observational study included 100 RD-PEN treatment episodes with evaluable 3-month outcomes. Composite response was defined as a ≥50% or ≥4-point reduction in Numeric Rating Scale (NRS) score, or a ≥30% or ≥2-point reduction with documented improvement in walking capacity. Eight candidate variables were entered into the initial multivariable logistic model, followed by backward likelihood-ratio elimination. The 6-month composite response was a secondary outcome, and NRS-only responses at 3 and 6 months were sensitivity outcomes. Results: At 3 months, 42 of 100 episodes responded. Prior lumbar surgery (adjusted odds ratio [OR], 0.23; 95% confidence interval [CI], 0.08–0.68; p = 0.008) and moderate-to-severe central canal stenosis (OR, 0.29; 95% CI, 0.11–0.76; p = 0.012) were associated with lower response odds, whereas a left-sided procedure was associated with higher odds (OR, 2.95; 95% CI, 1.20–7.23; p = 0.018). Shorter pain duration (<12 months) showed an imprecise association with higher response odds (OR, 3.40; 95% CI, 0.87–13.38; p = 0.079). Among 84 evaluable episodes at 6 months, prior surgery remained associated with lower response odds; NRS-only estimates were directionally similar. Intradiscal contrast spread occurred in 6 of 184 fluoroscopy-evaluable procedures (3.3%). Conclusions: Prior lumbar surgery and moderate-to-severe central canal stenosis were associated with lower 3-month response odds after RD-PEN, whereas a left-sided procedure was associated with higher odds. The laterality association did not reach statistical significance in the 6-month composite or NRS-only analyses and remained exploratory and potentially setting-specific.